Carnobacteriocin BM1

General Information


DRACP ID  DRACP03522

Peptide Name   Carnobacteriocin BM1

Sequence  AISYGNGVYCNKEKCWVNKAENKQAITGIVIGGWASSLAGMGH

Sequence Length  43

UniProt ID  P38579 

PubChem CID  Not available

Origin  Bacteria

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03522

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C199H310N56O59S3

Absent amino acids  DFPR

Common amino acids  G

Mass  527653

Pl  8.76

Basic residues  5

Acidic residues  2

Hydrophobic residues  15

Net charge  3

Boman Index  -2371

Hydrophobicity  -7.67

Aliphatic Index  77.21

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  14105

Absorbance 280nm  335.83

Polar residues  19

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 19271288

Title  Interactions between two carnobacteriocins Cbn BM1 and Cbn B2 from Carnobacterium maltaromaticum CP5 on target bacteria and Caco-2 cells

Doi Not available

Year  2009

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  6216

DRACP is developed by Dr.Zheng's team.